- Home
- XOMA vs TVGN Comparison
XOMA vs TVGN Comparison
Compare XOMA & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XOMA
- TVGN
- Stock Information
- Founded
- XOMA 1981
- TVGN 2020
- Country
- XOMA United States
- TVGN United States
- Employees
- XOMA N/A
- TVGN N/A
- Industry
- XOMA Biotechnology: Pharmaceutical Preparations
- TVGN Blank Checks
- Sector
- XOMA Health Care
- TVGN Finance
- Exchange
- XOMA Nasdaq
- TVGN Nasdaq
- Market Cap
- XOMA 250.1M
- TVGN 222.3M
- IPO Year
- XOMA N/A
- TVGN N/A
- Fundamental
- Price
- XOMA $19.30
- TVGN $1.09
- Analyst Decision
- XOMA Strong Buy
- TVGN Strong Buy
- Analyst Count
- XOMA 2
- TVGN 1
- Target Price
- XOMA $72.00
- TVGN $10.00
- AVG Volume (30 Days)
- XOMA 30.1K
- TVGN 427.0K
- Earning Date
- XOMA 03-17-2025
- TVGN 05-28-2025
- Dividend Yield
- XOMA N/A
- TVGN N/A
- EPS Growth
- XOMA N/A
- TVGN N/A
- EPS
- XOMA N/A
- TVGN N/A
- Revenue
- XOMA $28,487,000.00
- TVGN N/A
- Revenue This Year
- XOMA $29.60
- TVGN N/A
- Revenue Next Year
- XOMA $34.18
- TVGN N/A
- P/E Ratio
- XOMA N/A
- TVGN N/A
- Revenue Growth
- XOMA 498.72
- TVGN N/A
- 52 Week Low
- XOMA $19.12
- TVGN $0.26
- 52 Week High
- XOMA $35.00
- TVGN $4.78
- Technical
- Relative Strength Index (RSI)
- XOMA 27.79
- TVGN 40.90
- Support Level
- XOMA $20.45
- TVGN $1.13
- Resistance Level
- XOMA $21.45
- TVGN $1.22
- Average True Range (ATR)
- XOMA 0.80
- TVGN 0.07
- MACD
- XOMA 0.05
- TVGN 0.00
- Stochastic Oscillator
- XOMA 6.49
- TVGN 5.56
About XOMA XOMA Corporation
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes ("CD8+ CTLs" or "CTLs"), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.